Core Laboratories (CLB) Misses Q2 EPS by 2c; offers guidance
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $11.46 -0.95%
EPS Growth %: +36.4%
Financial Fact:
Services: 114.14M
Today's EPS Names:
CRMT, More
EPS Growth %: +36.4%
Financial Fact:
Services: 114.14M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Core Laboratories (NYSE: CLB) reported Q2 EPS of $0.22, $0.02 worse than the analyst estimate of $0.24. Revenue for the quarter came in at $130.6 million versus the consensus estimate of $134.06 million.
GUIDANCE:
Core Laboratories sees Q3 2024 EPS of $0.23-$0.27, versus the consensus of $0.25. Core Laboratories sees Q3 2024 revenue of $131-137 million, versus the consensus of $135.9 million.
For earnings history and earnings-related data on Core Laboratories (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- JPMorgan Upgrades Nanya Technology Corp (2408:TT) to Overweight
- Raymond James Upgrades Aecon Group (ARE:CN) (AEGXF) to Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
